I'm prepared to accept it is a risk to the trial recruitment rate. But the gross impact is minimal (8 centres out of 29), so it isn't really worth worrying about. The bigger risk is that management and the board have set a recruitment rate target of 16 patients per quarter, which is significantly greater than 3, 3 and 6 we saw in the 9 months to September, 2024. The quarterly will be interesting!
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.28M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 352684 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 54843 | 3 |
View Market Depth
| Last trade - 10.11am 17/06/2025 (20 minute delay) ? |
| CYP (ASX) Chart |
Day chart unavailable